266 related articles for article (PubMed ID: 16799620)
21. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
22. Amphiregulin: a new growth factor in hepatocarcinogenesis.
Berasain C; Castillo J; PerugorrÃa MJ; Prieto J; Avila MA
Cancer Lett; 2007 Aug; 254(1):30-41. PubMed ID: 17321672
[TBL] [Abstract][Full Text] [Related]
23. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
24. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP
Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939
[TBL] [Abstract][Full Text] [Related]
25. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
26. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
[TBL] [Abstract][Full Text] [Related]
27. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
28. Survival and apoptosis: a dysregulated balance in liver cancer.
Fabregat I; Roncero C; Fernández M
Liver Int; 2007 Mar; 27(2):155-62. PubMed ID: 17311609
[TBL] [Abstract][Full Text] [Related]
29. [Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?].
Nussbaum T; Vreden S; Farsad M; Schirmacher P; Breuhahn K
Verh Dtsch Ges Pathol; 2005; 89():254-60. PubMed ID: 18035699
[TBL] [Abstract][Full Text] [Related]
30. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP
Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592
[TBL] [Abstract][Full Text] [Related]
31. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.
Breuhahn K; Schirmacher P
World J Gastroenterol; 2008 Mar; 14(11):1690-8. PubMed ID: 18350600
[TBL] [Abstract][Full Text] [Related]
32. [Growth factors in liver regeneration and hepatocarcinogenesis].
Schirmacher P; Odenthal M; Steinberg P; Dienes HP
Verh Dtsch Ges Pathol; 1995; 79():55-60. PubMed ID: 8600695
[TBL] [Abstract][Full Text] [Related]
33. Signaling networks in human hepatocarcinogenesis--novel aspects and therapeutic options.
Breuhahn K; Schirmacher P
Prog Mol Biol Transl Sci; 2010; 97():251-77. PubMed ID: 21074736
[TBL] [Abstract][Full Text] [Related]
34. Characterization of glutathione efflux from Hep G2 cells.
Liu JH; Miyakawa H; Liu J; Mori K; Takano T; Marumo F; Sato C
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):261-70. PubMed ID: 7827801
[TBL] [Abstract][Full Text] [Related]
35. The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
Whittaker S; Marais R; Zhu AX
Oncogene; 2010 Sep; 29(36):4989-5005. PubMed ID: 20639898
[TBL] [Abstract][Full Text] [Related]
36. [HGF/c-Met and metastasis of hepatocellular carcinoma].
Xie B; Dong JH
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):396-8. PubMed ID: 15918987
[No Abstract] [Full Text] [Related]
37. High aromatase activity and overexpression of epidermal growth factor receptor in fibrolamellar hepatocellular carcinoma in a child.
Muramori K; Taguchi S; Taguchi T; Kohashi K; Furuya K; Tokuda K; Ishii E
J Pediatr Hematol Oncol; 2011 Jul; 33(5):e195-7. PubMed ID: 21552145
[TBL] [Abstract][Full Text] [Related]
38. Rat hepatoproliferin revealed the status of a complete hepatomitogen in human hepatoma cells.
Oosthuizen MM; Ndaba N; Myburgh JA
Transplant Proc; 2005; 37(1):89-92. PubMed ID: 15808557
[TBL] [Abstract][Full Text] [Related]
39. [Expression of epidermal growth factor and its receptor in human primary hepatocellular carcinoma].
Wu X; Peng L
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):544-6. PubMed ID: 10073004
[No Abstract] [Full Text] [Related]
40. Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges.
Giacomin A; Sergio A; Vanin V; Gazzola A; Cazzagon N; Farinati F
Dig Dis; 2012; 30(3):284-8. PubMed ID: 22722553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
